Promising discoveries emerge from Oklahoma Startups

INVESTMENTS

BPEndo

TETHEREX

Investments led by i2E, keep groundbreaking medical technologies on track to benefit patients worldwide

For the past 24 years, i2E, Inc. and its investment arm, Plains Ventures, has played a major role in funding Oklahoma researchers and entrepreneurs by investing more than $35 million in Oklahoma bioscience companies that are developing new therapeutics, developing new medical devices, developing new diagnostic tools or providing support technologies for the bioscience industry and industry research and development. i2E’s portfolio companies are working to advance medical technologies that prevent hospital acquired infections, help physicians visualize colonoscopy procedures more clearly, protect against accidental catheter disconnection, provide pain-free therapeutics that combat eye disease, reverse hearing loss and much more. Even as these new technologies edge closer to bringing their life changing outcomes to patients around the world, other promising discoveries continue to emerge from Oklahoma laboratories. Millions of dollars will be required to advance them to the market. In Oklahoma, life science entrepreneurs will continue to turn to i2E for the critical seed funding needed to survive the initial stages of development. In the past 2 years, i2E Inc. has invested nearly $7 million in 8 bioscience or life science companies.

The following is a look at some of the bioscience companies that i2E investments have supported over the years.

All these diverse medical technologies share a common bond. i2E, Inc., led early investment rounds that provided critical funding ensuring the companies created to advance the new drugs and medical devices have the capital necessary to successfully negotiate the development and testing phase.